Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Akzo Nobel scraps plan to divest Organon through IPO

Executive Summary

Dutch chemical giant Akzo Nobel plans to spin off 20-30% of its Organon NV pharmaceutical subsidiary in an IPO on Amsterdam's Euronext exchange. Some analysts estimate the offering will value Organon between €8-9bn ($10.2-11.5bn).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • Spin-Off
    • IPO

Related Companies

UsernamePublicRestriction

Register